The Sino-Singapore Group announced that the company plans to use its own capital as a limited partner to pledge no more than 20 million yuan to Anhui Daotong Yaohui Equity Investment Partnership, accounting for no more than 5% of the total amount pledged by the fund. The fund size is no more than 1.1 billion yuan, focusing on equity investment in medical devices and biotechnology.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.